Health Archive » May, 2026

Health - May, 2026

356 articles

• Fla. Panel Upholds Reduced $4M Car Crash Verdict
• Telehealth Co. Hims Likely To Get Suicide Suit Trimmed
• Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now
• Joint Venture Can't Claim Small Biz Status, Judge Finds
• Ohio AG Says Cigna Can't Use Sherman Act To Ax State Case
• Texas Justices Deny Review Of Heartbeat Act Procedure
• Teva Ruling Offers Patentees New Support For Genus Claims
• Blood Test Lab Owner Gets 4 Years For $11M Tax Evasion
• Full 4th Circ. To Rethink W.Va., Md. 340B Drug Discount Laws
• DOJ Final Rule On Medical Pot Comes Under New Challenge
• UK Litigation Roundup: Here's What You Missed In London
• U. Of Mich. Surgeon Sues Over Teaching Suspension
• Recent Actions Signal Increased NYDFS Health Cyber Focus
• Taxation With Representation: Latham, White & Case, Vischer
• Your Next Litigation Hold Should Cover AI Chat Logs
• UnitedHealthcare Defrauded Mass. Of $100M, AG Says
• Cuts To Benefits Come With Risks For Employers, Attys Say
• Calif. AG Sues 23andMe Over Lapses In Genetic Data Security
• Hospital's $11.5M COVID Tax Credit Suit Clears Dismissal Bid
• Wash. Justices Float AI Hypotheticals In Hospital Pixel Case
• Trans Patients Say Stanford Can't Give DOJ Medical Records
• Texas Panel Tosses Med Mal Suit Over Flawed Expert Report
• Injury Law Roundup: Freight Brokers, Uber Lose Key Cases
• Hospital Operator, Execs Ink $32M FCA Settlement With Feds
• McDermott-Led Ampersand Clinches $1.5B Fund
• J&J Unit Cleared In Blood Pump Patent Suit In Mass.
• UnitedHealthcare Unit Settles PrEP Coverage Fight
• DOJ To Speed Up Review Of Qui Tam Benefits Fraud Claims
• UConn Escapes Surgeon's ADA Damages Claim In Bias Suit
• Hospital Network Left Bonuses Out Of OT Pay, Suit Says
• Abbott Labs Settles Ill. Genetic Privacy Suit
• Legislative Update: Cannabis And Psychedelics Bill Roundup
• Mich. Judge Dismisses Data Breach Class Action
• High Court's Abortion Pill Stay Reinforces Appellate Principles
• Ex-Perrigo Workers Say Lax Security Led To Cyberattack
• 1st Circ. Rejects Bid To Halt Deportation Over Teens' Health
• Husch Blackwell Adds Manatt Healthcare Duo In LA
• 9th Circ. Won't Revisit FCA Ruling Over Drug Price Program
• Studying Foreign Languages Makes Me A Better Lawyer
• Meta To Head To Aug. Advisory Trial In States' Addiction MDL
• Ex-Doximity Exec Gets 2 Years For Insider Trading Scheme
• Pharmacies Beat Fla. Hospitals' Opioids Suit
• 3 Generic Drug Antitrust Deals Totaling $17.9M Get Final Nod
• ProPublica Denied Access To Ranbaxy Antitrust MDL Docs
• Pharmacies Hit With Injunction In Gilead Counterfeit Drug Row
• 10th Circ. Affirms Dentist's 3½-Year Sentence For Tax Evasion
• Stock Trade Co. Wants Out Of Mallinckrodt Clawback Suit
• Judge Doubts Prison Bureau Claim Trans Care Isn't Banned
• NY-Presbyterian Says DOJ's Antitrust Case Is Misguided
• US Tells Justices To Hold 'Lightning Rod' Health Ministry Case
• 3 States Back Advocate's Challenge To DOJ Medical Pot Rule
• Ex-Federal Prosecutor Picked As NJ Insurance Fraud Chief
• Humana Investor Sues Over Alleged Kickback Scheme
• Travelers Can't Halt Water Damage Fight, Senior Home Says
• Sher Tremonte Hires DOJ Antitrust Litigation Director
• 9th Circ. Won't Revive Wash. City Workers' Vax Mandate Suit
• Seattle Hospital Loses Appeal Of Dr.'s $21M Race Bias Verdict
• 6th Circ. Rejects Mich. Reproductive Rights Challenge
• Ga. Panel Reinstates Malpractice Suit Against Chiropractor
• 9th Circ. Backs Reinstating DEI Grants Nixed By Trump
• AI Due Diligence Is Key For Healthcare M&A
• Conn. Drug Price Law Still Allows Hikes, 2nd Circ. Told
• Calif. Atty Says Pot Rescheduling Keeps LA Appeal Alive
• Beasley Allen Fails To Overturn J&J Talc Disqualification
• Squires' Institution Flips Are Increasing Uncertainty At PTAB
• Judge Tosses Anti-Pot Suit Over CMS Hemp Benefits Program
• Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B
• Mich. Hospital Breach Suit Belongs In State Court, Judge Says
• Law360 Reveals Titans Of The Plaintiffs Bar
• Ringleader Of $250M COVID Child Meals Fraud Gets 41 Years
• Corewell Health Faces Suit Over Alleged 'Fake' Medical Debt
• 4th Circ. Says Atty's Hospital Fraud Claims Not Med Mal
• Health Workers Say US Solicitor Wrong In NY Vax Case
• Healthcare Orgs Push DC Court To Block Student Loan Caps
• Opioid Plaintiffs Want Sanctions Over McKinsey Deletions
• Bracing For Enforcers' Growing Focus On Behavioral Health
• Md. Docs Seek $50M After DOJ's Failed Russia Case
• Hospital Pulls $1M Medicare Suit Against UnitedHealthcare
• Hospital Accused Of Shorting Workers' Overtime
• Don't Miss It: Cooley, Simpson Thacher Steer Hot Deals
• Sizing Up The Rescheduling Hurdles Medical Pot Cos. Face
• Green Card Candidates To Now Apply From Abroad, Feds Say
• Trump's Melding Of Politics, Antitrust Hard To Roll Back
• Home Care Agencies' Wage Settlement Rejected Again
• UK Litigation Roundup: Here's What You Missed In London
• PBM Swaps Cravath For WilmerHale In Price-Fixing Suit
• 9th Circ. Told To Reject J&J Unit's $442M Antitrust Appeal
• Texas Panel Says Patient Fall Claim Is Med Mal, Tosses Suit
• FTC's Gender Care Policy Might Not Sink Probe, Judge Says
• Legislative Update: Cannabis And Psychedelics Bill Roundup
• DOJ Activity Indicates Rising Antitrust Risk For Hospitals
• Class Actions At The Circuit Courts: May Lessons
• Immunity Bid Can't Stop Discovery In THC Abuse Registry Suit
• Clark Hill Exits NJ Health Noncompete Dispute After DQ Bid
• Medical Practice Calls $49M Missed Cancer Verdict 'Unjust'
• Meta, Others Settle Bellwether School Case Set For June Trial
• Barnes & Thornburg Adds Boston Litigator From Nutter
• AmeriHealth Unit, PBM Sued Over Prescription Claim Fees
• Ga. Panel Says Trial Court Wrongly Denied New Med Mal Trial
• NY Times Word Puzzles Make Me A Better Lawyer
• DOJ, Drugmakers Spar After Justices Snub 6 Negotiation Suits
• Anthem Affiliates Can't Duck Suit Over Colo. Claims
• 1st Circ. Allows Transfer Of RI Youth Care Info To Texas Court
• Refusing Sandoz Parent Dismissal 'Clear Error,' Court Told
• Eli Lilly Loses Bid To Limit Ex-FDA Chief's Take In GLP-1 MDL
• Antivax Health Workers Fight Uphill At 9th Circ. Over Firings
• NY Hospital Strikes Deal In Suit Over Retirement Plan Lineup
• Engaging With FDA's New Complete Response Letter Policy
• Eli Lilly Paying Up To $202M In Genetic Medicine Deal
• Lloyd's Can't Undo Remand Order In Hurricane Damage Fight
• Tracking Tech Suit Is A Risk Management Reminder For Cos.
• Pa. AG Aims To Revive Ban On Medicaid-Paid Abortions
• FTC 'Close' To Final PBM Insulin Price Deal With OptumRx
• DOJ's Embrace Of Data Sets Off Compliance 'Arms Race'
• Modivcare To Have Evidence Hearing On Firm's Contempt Bid
• Law School's Missed Lesson: Diagnose Before Arguing
• Quinn Emanuel Owes More Sanctions In Guardant Fight
• Calif. Urges 9th Circ. To Revive Pay-For-Delay Restrictions
• McDermott-Led Albaron Wraps $185M Healthcare Fund
• Cigna Can't Knock Out 401(k) Forfeiture, Fund Suit
• Squires Ends Samsung-Requested IPR Over Related PGR
• Fed. Circ. Rehearing Sought In $18M Penile Implant Dispute
• Payroll Vendor Not Care Workers' Employer, 3rd Circ. Says
• TikTok Says 'Market Exploitation' Doesn't Give NC Jurisdiction
• Medtronic Whistleblower Suit Stayed Amid Settlement Talks
• Trump's Psychedelics EO Creates A Regulatory Collision
• Mentari, InMed Merge In Deal Backed By $290M Funding
• States Sue Over Student Loan Limits On Professional Degrees
• Mich. Panel Says Gauze, Gloves Not Tax-Exempt Prosthetics
• Barnes & Thornburg Adds 3 Healthcare Attys In DC, Chicago
• Non-Clients Say Katten Attys' 'Double-Cross' Bars Immunity
• Mich. Hospitals Say CVS Diverted $66M In 340B Drug Savings
• Becoming The Biz-Savvy GC That Portfolio Companies Need
• Feds Say High Court Should Skip Religious Bias Vax Fight
• AI Regulatory Gaps May Fuel FCA Enforcement Action
• Anthem Inks $3.6M Settlement In Proton Beam Therapy Suit
• Groq, Doctor Strike Deal To End 'Groq Health' TM Suit
• CDC Imposes Entry Restrictions For Ebola Outbreak
• Boeing Owed Duty To Worker's Future Kid, Wash. Panel Says
• Fla. Hospitals Seek $10.5M In Fees In Safety Rating Fight
• Woman Says Spinal Device Caused Permanent Nerve Damage
• Fla. Hospital Patients Denied Rethink On Class Cert.
• Health Co. Wants Kirkland Off IP Case For 'Cardinal Sin'
• Ill. Panel Sides With AbbVie In Eye-Stent Injury Suit
• Senior Home Says Colo. Is Right Venue For Insurance Dispute
• Justices Won't Revive LA Schools COVID Vaccine Policy Suit
• Pa. High Court Snapshot: Wegmans, PennDot Top May Lineup
• PBMs Tell Mich. Court They're Not To Blame For Opioid Abuse
• Aetna Denied A Freeze On Trans Facial Surgery Order
• Hawaiian Scholarship Suit Imperils $2.2M In Work, Court Told
• Boies Schiller, Firm Partner Dropped From Fla. Fee Suit
• ADA Suit Can't Seek Rewrite Of Psilocybin Law, Ore. Says
• Morgan & Morgan Atty Barred From Harvard Suit Over AI Error
• Takeda Liable In IBS Drug Pay-For-Delay Trial
• Catching Up With Delaware's Chancery Court
• Justices Deny Eli Lilly's Qui Tam Constitutional Challenge
• Revised Suit Against Healthcare Data Co. Still Fails, Court Told
• Colo. Justices Tell Hospital To Resume Gender-Affirming Care
• Mangione Can Suppress Some Evidence In NY Murder Case
• High Court Spurns Pharma Challenges To IRA Drug Price Talks
• Judges On AI: How Courts Can Survive The Tech Revolution
• 'Skinny Label' Arguments Spotlight Induced Infringement Risk
• Pharmacies Stuck With CVS Arbitration Mandate At 9th Circ.
• Edwards Investors Sue In Chancery Over $16.4B Stock Drop
• Texas Hospital Creates 'De-Transition Clinic' After Settlement
• Spokane Firefighters Denied Early Win In Vax Exemption Suit
• Minn. Twins Doctor Can't Claim Immunity In Player Death Suit
• 4th Circ. Hands Express Scripts Jury Trial In W.Va. Opioid Suit
• US Opens Duty Probe Into Chinese Medicinal Chemical
• McKesson Settles Trade Secrets Suit Against Former Exec
• $19.2M Joint Juice Deal Ends Calif. False Ad Suit
• DOJ Says Grant Condition Stay Must Stop At 3 Programs
• Texas Justices Revive Anti-SLAPP Bid In Abortion Fund Suit
• Ex-HR Director Drops FMLA Suit Against Telehealth Co.
• NC Social Worker Wants Resentencing In Medicaid Fraud Suit
• Nursing Home Ch. 11 Trustee Sues Ex-Execs Over Lost Funds
• Veterans Group Asks Fed. Circ. To Toss VA Abortion Ban Rule
• 3 AI Adoption Mistakes GCs Should Avoid
• 'Drastic Overreach': Judge Nixes DOJ Trans Care Subpoena
• NJ Doctor Prescribed Medical Marijuana To Kids, AG Says
• Mich. City, Mayor Deny Conspiracy To Harass Group Home
• Legislative Update: Cannabis And Psychedelics Bill Roundup
• NC Republicans Want Fetal Personhood Question On '26 Ballot
• Takeda To Pay $13.6M Over Antidepressant Drug Kickbacks
• Pa. Psych Hospital Faces Multiple Abuse Lawsuits
• Moda Health Settles Wilderness Therapy Coverage Suit
• DOJ Says Yale's Medical School Discriminates Based On Race
• Albertsons Not Covered In Opioid Litigation, Del. Judge Says
• High Court Maintains Abortion Pill Access Amid Circuit Appeal
• Carbon Health Strikes $12M Creditor Deal In Ch. 11
• Takeda Cashed In From Delay Of Generic IBS Drug, Jury Told
• Hillrom Says Antitrust Row Rival Must Name Litigation Funder
• BeiGene Must Face AbbVie's Chemical Trade Secret Claims
• Playing Basketball Makes Me A Better Lawyer
• NC Healthcare Workers Get Final Nod On $1.5M Wage Deal
• EPA Listing Signals New Scrutiny Of Drugs In Drinking Water
• Time For Trial, Judge Says, Nixing DQ Appeal In Generics MDL
• Blank Rome Adds Husch Blackwell's Dallas Leader
• HealthSplash CEO Found Guilty In $450M Medicare Fraud Trial
• CMS To Keep $1.3B From Calif., Halt New Hospice Enrollment
• 3 NJ Employers Accused Of Pregnancy Discrimination
• Walgreens Investors' Opioid Suit Is Time-Barred, Judge Says
• Washington Hits Providence Health With Pregnancy Bias Suit
• Bayer, Buyers Get Final OK Of $4.85M Benzene Settlement
• 5th Circ.'s Abortion Pill Order Is Shaky On Multiple Grounds
• DOJ Fraud Division Set To Shake Up White-Collar Enforcement
• Becton Hernia Mesh Antitrust Case Survives Dismissal
• The Biz Court Digest: Georgia Court Has Business On Its Mind
• Provider Says NY Is On The Hook For $3.3M Medicaid Shortfall
• Conn. Doctor Asked To Pay $880K In IVF Fraud Dispute
• 5 Takeaways From Justices' Subpoena Fight Ruling
• Crowell & Moring Opens Minneapolis Office With 8 Lawyers
• ​​​​​​​Amazon Beats Sanctions Bid Over Supplement Product Pages
• Cigna Says HIPAA Doesn't Save Website Privacy Suit
• Attys For Tufts Profs Didn't Blink In A Tenure Standoff
• DOJ Playing 'Dirty Pool' With Hospital In Trans Care Subpoena
• White & Case Seeks Contempt In Modivcare Ch. 11 Fee Spat
• AliveCor Wants Apple Health Monitor Patent Claims Tossed
• Drone Co. Skirts Unfair Biz Practices Claim In Ex-VP's Pay Suit
• Texas AG Targets CVS DEI Program, Threatens Fraud Probe
• Commerce Details Path To Discount For 100% Pharma Tariff
• 6th Circ. Says Jailers Entitled To Immunity In Detainee Death
• Nurse's Family Fights Workers' Comp Loss Over COVID Death
• Mass. Draft Regs Signal Nationwide Scrutiny Of Junk Fees
• Fox Rothschild Adds Trial Partner From Nelson Mullins In Fla.
• Mass. Appeals Court Tosses Convictions For Assault On Police
• 4 Emerging Approaches To AI Protective Order Language
• Pa. Panel Struggles With Oversight Of $2.2B Opioid Fund
• Makary Out As FDA Commissioner, Trump Says
• Wash. Says Novartis Isn't Harmed By 340B Drug Pricing Law
• Pa. Law Firm, Doctors Can't Shake Uber, FedEx RICO Suit
• 5th Circ. Wary To Flip IP Suit's 'Case-Terminating Sanctions'
• Transgender Minor Patients Seek To Block DOJ Subpoenas
• Beauty Tech Co. Execs Beat Investor Suit For Good
• Johns Hopkins Keeps Trial Win In Fatal Heart Condition Suit
• Pharma CEO's Role In Ex-Exec's Contract Permits Deposition
• Fla. Panel Denies Arbitration In Nursing Home Death Suit
• What Justices Are Focusing On In 'Skinny Label' Patent Case
• Swedish Health $86M Wage Deal Secures Initial OK
• NYC Sanctioned For Sluggish Discovery In IVF Sex Bias Suit
• Mich. Providers Say Jury Must Weigh Allstate RICO Claims
• COVID Hazard Pay Counts Toward OT, 11th Circ. Rules
• Justices Extend Stay On 5th Circ. Mifepristone Decision
• Accelerated Psychedelic Therapy Pathways Require Caution
• Plaintiffs' Attys Sanctioned In Tylenol MDL, Sparking Appeal
• Heppner Ruling Left AI Privilege Risk For Lawyers Unresolved
• Verano Says Receipt Suit Should Be Arbitrated Or Dismissed
• Agencies Pitch Employers Offering Voluntary Fertility Benefits
• Prison Healthcare Co. YesCare Hits Ch. 11, Citing Lawsuits
• FTC's Gender-Care Probe Likely Retaliatory, Judge Says
• Care Provider Says Medicare Wrongly Denied Reimbursement
• 6th Circ. Backs Ex-Fed Worker's Long COVID Benefits Denial
• Judge Probes Cert. For Diverse Worker Class In No-Poach Suit
• Ohio Health System Looks To Toss DOJ Antitrust Case
• Minnesota Foster Parents Ask Justices To Revisit ICWA Fight
• White House Defends Pardon Process Following Dem Inquiry
• Tort Report: Tesla's Legal Exposure Seen As High As $14.5B
• Carbon Health Gets $11M DIP Hike As Mediation Continues
• Covington, Cooley Lead Drugmaker Odyssey's $279M IPO
• Ex-NFL Player Gets 16-Plus Years For $200M Healthcare Fraud
• Squires Says Yes To 7 Patent Petitions, No To A Dozen More
• Don't Miss It: Paul Hastings, V&E Steer Latest Hot Deals
• The Ethics And Practicalities Of Representing AI Agents
• 4th Circ. Backs Toss Of Fired Worker's Whistleblower Suit
• Walgreens Loses Atty Sanctions Bid In Georgia Bias Suit
• Using FCA To Go After DEI Poses Legal Hurdles For DOJ
• NC Panel Rules Prior Verdict Bars Hospital Negligence Case
• 9th Circ. Backs Lead Choice In Super Micro Investor Fraud Suit
• La. Says Mailed Abortion Pills Harm State Budget, Sovereignty
• Judge, In 'Difficult Position,' OKs Rare Patent Defense
• Bayer Sued Over Healthy Sperm Claim On 'One A Day' Pill
• Meta Seeks To Toss LA Jury's Social Media Addiction Verdict
• UK Says Welltower's Senior Home Deals May Hurt Competition
• California Tribe Seeks Summary Win Over Opioid Clinic Denial
• Health Cos. Must Act Quickly To Secure Digital Front Doors
• Ex‑Novartis Atty Wins Revival Of Whistleblower Claims
• Davis Polk-Led Roche To Pay Up To $1.05B For PathAI
• King & Spalding Adds Congressional Health Policy Duo In DC
• GAO Finds Issues With VA's Equipment Maintenance Process
• New PBGC Amicus Program Offers Input On Important Cases
• Hospital Suspects DOJ Is Forum Shopping For Trans Records
• Insurer Beats Calif. Health Group's Discovery Costs Suit
• Harvard Pilgrim Sued Over 'Ghost' Mental Health Network
• Speed Jigsaw Puzzling Makes Me A Better Lawyer
• Fla. Court Asked To Lift Freeze In $91M Fake Health Plans Suit
• Colo. Appeals Court Mulls POA's Authority On Arbitration
• Judge Questions OMB Justification For Voiding Grants
• Prospect Medical Captive Insurer Files Ch. 15 In Texas
• Full 11th Circ. Denies Medical Act Remedy In Discharge Suit
• Pharmacy Axed Worker For Joining Army Reserve, Suit Says
• Judge Won't Certify Minn. Fraud Question In Cancer Drug MDL
• Bloom Nu Energy Drinks Have Artificial Ingredients, Suit Says
• Documenting Business Purpose After IRS' 10th Circ. Win
• Calif. Justices Seem Divided On Gilead HIV Negligence Claim
• 9th Circ. Won't Revive Hospital Workers' Vaccine Bias Suit
• Nursing Home Co. Can't Stave Off EEOC Harassment Trial
• CellCentric Closes Latest Funding Round With $220M In Tow
• Pot Patients Defend Claims In Dispensary Data Privacy Suit
• DC Circ. Judge Jabs Pharma Atty For 10 Minutes In Price Fight
• Cannabis Giants Sued Over Mental Health Marketing
• Patient Data Tracking Suit Sent Back To Wis. State Court
• Ex-CEO Gets 5 Years In Prison For $212.5M Fraud Case
• ERISA Recap: 5 Litigation Developments From April
• Apple Urges Full Fed. Circ. To Undo Original Watch Import Ban
• Wash. Panel Revives GLP-1 Health Plan Coverage Fight
• $100M AI Investment Suit Must Be Arbitrated, Financier Says
• Pa. Sues Character.ai For Bot Acting Like A Doctor
• Mylan Strikes $4.5M Deal With Maryland Over EpiPen Pricing
• 11th Circ. Upholds Sentences In Medical Device Fraud Case
• Texas Appeals Court Wary Of Reviving Trustee's $100M Claim
• CooperSurgical Strikes Deal To End Embryo Loss Class Suit
• How Oregon Ruling Affects Federal Gender Care Crackdown
• Ga. Panel Weighs Evidence Rules In Parents' Bid For New Trial
• Sandoz, Novartis Must Face Generics Claims From GM, Others
• Sponsor Suit Moot After Immigrant Kids Released, Feds Say
• High Court Clarity On Subpoenas Creates Murky Path For AGs
• Idaho Farmers Group Gets DOL Approval For Health Plan
• AI Hallucinations Kill Montreal Arbitrator's Decision
• FTC Deal Bars Kochava From Selling Sensitive Location Data
• Hedge Fund Says Expert Loss Isn't Fatal To Spoofing Case
• 6th Circ. Sets Standard For NLRB Injunctions In Hospital Case
• Md. Hospital Had Duty To Warn Of Patient's Violent Statements
• Orrick Partner Jumps To Pillsbury IP Team In LA
• Hospital Group Calls Anthem's Out-Of-Network Plan Unlawful
• NC Dems Propose Ballot Measure To Decriminalize Marijuana
• Judge Shuts Down Invalidity Theory In Abiomed IP Case
• Suit's Dismissal Would Not Settle Gold Card Visa's Legality
• 4th Circ. Says Abortion Protester Doesn't Deserve Jury Trial
• 2 AI Snafus Show Why Attys Can't Outsource Judgment
• NY Opioid Antagonist Mandate Leaves Employers Guessing
• Supplement Co. Says False Labeling Plaintiff Never Saw Ads
• Pa. Co. Inks $1.2M Deal To Settle FCA Allegations
• Supreme Court Halts Abortion Drug Telehealth Ruling
• Justices Won't Hear Anti-Vaxxer Medical Board Suit
• NYDFS Fines Delta Dental $2.25M Over MOVEit Data Breach
• Pharma Aims Torpedo At FCA After Bombshell 9th Circ. Ruling
• Trump's Fixed-Price Contract Default Could Raise Gov't Costs
• Judge, Atty Get In Shouting Match At Fatal Overdose Trial
• Diagnostic Imaging Co. Pays $8.3M To End FCA Case
• Texas High Court Revives Delta-8 THC Restrictions
• Hospitals Say HHS Is Withholding Safety Net Reimbursements
• 5th Circ. Pauses Mail-Order Access To Abortion Pills
• Benefits Co. Inks $3M Deal To End Worker's Tobacco Fee Suit
• Calif. Case Raises Questions For Medical Practice Investors
• 5 Argument Sessions Benefits Attys Should Watch In May
• Previewing FDA Preapproval Access In Psychedelics EO
• Calif. Sued Over Ballot Measure For Health Clinic Fund Use
• DOJ Asks 4th Circ. To Revive Children's Hospital Subpoena
• Med Groups Say HHS Stalling Challenge To Vax Changes
• Sidley, Goodwin Lead $1.1B Take-Private Deal For Esperion
• Medical Practice's Assets Targeted After $49M Verdict
• Ex-Budget Official's Sentencing Set Before 2nd Bribery Trial
• Mylan Inks $11M Deal With NC Over EpiPen Pricing
• UK Litigation Roundup: Here's What You Missed In London
• Nelson Mullins Hires Career Faegre Drinker Pharma Trial Atty
• Humana Investor Suit Largely Survives Dismissal Bid